1. Home
  2. DGHI vs QNCX Comparison

DGHI vs QNCX Comparison

Compare DGHI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • QNCX
  • Stock Information
  • Founded
  • DGHI 2017
  • QNCX 2012
  • Country
  • DGHI United States
  • QNCX United States
  • Employees
  • DGHI N/A
  • QNCX N/A
  • Industry
  • DGHI Finance: Consumer Services
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DGHI Finance
  • QNCX Health Care
  • Exchange
  • DGHI Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • DGHI 90.1M
  • QNCX 62.0M
  • IPO Year
  • DGHI N/A
  • QNCX 2019
  • Fundamental
  • Price
  • DGHI $3.03
  • QNCX $1.40
  • Analyst Decision
  • DGHI Strong Buy
  • QNCX Strong Buy
  • Analyst Count
  • DGHI 1
  • QNCX 4
  • Target Price
  • DGHI $2.50
  • QNCX $9.50
  • AVG Volume (30 Days)
  • DGHI 982.7K
  • QNCX 128.0K
  • Earning Date
  • DGHI 04-02-2025
  • QNCX 03-31-2025
  • Dividend Yield
  • DGHI N/A
  • QNCX N/A
  • EPS Growth
  • DGHI N/A
  • QNCX N/A
  • EPS
  • DGHI N/A
  • QNCX N/A
  • Revenue
  • DGHI $42,146,057.00
  • QNCX N/A
  • Revenue This Year
  • DGHI N/A
  • QNCX N/A
  • Revenue Next Year
  • DGHI N/A
  • QNCX N/A
  • P/E Ratio
  • DGHI N/A
  • QNCX N/A
  • Revenue Growth
  • DGHI 100.56
  • QNCX N/A
  • 52 Week Low
  • DGHI $0.84
  • QNCX $0.51
  • 52 Week High
  • DGHI $3.77
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 57.94
  • QNCX 35.89
  • Support Level
  • DGHI $2.81
  • QNCX $1.37
  • Resistance Level
  • DGHI $3.48
  • QNCX $1.69
  • Average True Range (ATR)
  • DGHI 0.47
  • QNCX 0.12
  • MACD
  • DGHI -0.01
  • QNCX -0.02
  • Stochastic Oscillator
  • DGHI 48.25
  • QNCX 7.32

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: